The Science of Medicare Reform

医疗保险改革的科学

基本信息

  • 批准号:
    8047224
  • 负责人:
  • 金额:
    $ 550.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application addresses the thematic area, "Using Science to Enable Health Care Reform." The future of the Medicare program poses one of the greatest policy challenges to the United States. This extraordinarily popular program has brought universal health insurance coverage to the elderly and others who would otherwise lack access to needed health services. The implementation of Medicare Part D to cover prescription drugs is widely viewed as a success; yet in several ways Medicare is an anachronism. First, its fee-for-service reimbursement system has all but vanished from private health insurance. Medicare imposes copayments and deductibles like commercial health insurance plans, but about 80% of beneficiaries have supplemental insurance, which reduces the out-of-pocket payments. Thus most beneficiaries do not fully consider costs-or even Medicare copayments-when making health care decisions. Second, research has demonstrated dramatic variation in per capita Medicare expenditures across regions of the U.S.-variation that cannot be explained by demographic or health characteristics. Yet high resource use regions do not have superior health outcomes. The services covered by Medicare may thus be a poor match to the needs of older Americans in many regions. Third, the program is the largest fiscal liability of the Federal government. The aging of the baby boomers will swell the population of Medicare beneficiaries. Absent program changes, Medicare expenditures will rise from 3% of gross domestic product today to 17% by 2082. This research collaboration will design and conduct Medicare-related research, policy simulation, and welfare analysis to address these issues. A multidisciplinary team spanning four institutions at the forefront of health economics and policy research- Stanford University, University of Southern California, RAND Corporation, and the University of California, Berkeley-will focus on solutions to ensure Medicare continues its legacy of success. The American Recovery and Reinvestment Act of 2009 provided an unprecedented $1.1 billion to explore comparative effectiveness research (CER). Yet specific applications of CER to the Medicare program do not yet exist. With these in mind, our Specific Aims are: 1) Develop intertemporal optimization models of plan choice in the Medicare Part D market; 2) Understand competition in the Medicare Part D marketplace; 3) Examine the consequences of FBD for utilization, health, and spending; 4) Apply comparative effectiveness analysis to identify clinical areas for potential savings in Medicare; and 5) Build a research network to support Medicare-related research and policy. We will promote collaboration and dissemination through various activities, including a national Medicare: Science and Policy Conference that will disseminate research findings and promote science-based Medicare reform. PUBLIC HEALTH RELEVANCE: This application focuses on solutions to ensure that Medicare continues its legacy of success. Our multidisciplinary team spanning four institutions at the forefront of health economics and policy research will design and conduct Medicare-related research, policy simulation, and welfare analysis that will focus on solutions to ensure Medicare continues its legacy of success.
描述(由申请人提供):本申请涉及的主题领域,“利用科学,使医疗保健改革。“医疗保险计划的未来对美国构成了最大的政策挑战之一。这项非常受欢迎的计划为老年人和其他无法获得所需医疗服务的人带来了全民医疗保险。医疗保险D部分的实施,以涵盖处方药被广泛认为是成功的,但在几个方面,医疗保险是一个时代错误。首先,它的按服务收费的报销制度几乎从私人医疗保险中消失了。医疗保险像商业健康保险计划一样征收共同负担费用和免赔额,但大约80%的受益人有补充保险,这减少了自付费用。因此,大多数受益人在做出医疗保健决策时并没有充分考虑成本,甚至没有考虑医疗保险的共同负担。其次,研究表明,美国各地区的人均医疗保险支出存在巨大差异。无法用人口统计学或健康特征解释的变化。然而,高资源使用地区并没有上级健康成果。因此,在许多地区,医疗保险所覆盖的服务可能与美国老年人的需求不匹配。第三,该计划是联邦政府最大的财政负债。婴儿潮一代的老龄化将扩大医疗保险受益人的人数。如果没有计划的变化,医疗保险支出将从今天占国内生产总值的3%上升到2082年的17%。这项研究合作将设计和进行医疗保险相关的研究,政策模拟和福利分析,以解决这些问题。一个跨学科的团队跨越四个机构在卫生经济学和政策研究的前沿-斯坦福大学,南加州大学,兰德公司和加州大学伯克利分校-将专注于解决方案,以确保医疗保险继续其成功的遗产。2009年的《美国复苏和再投资法案》提供了前所未有的11亿美元,用于探索比较有效性研究。然而,CER在医疗保险计划中的具体应用还不存在。考虑到这些,我们的具体目标是:1)在医疗保险D部分市场中开发计划选择的跨期优化模型; 2)了解医疗保险D部分市场的竞争; 3)检查FBD对利用率,健康和支出的影响; 4)应用比较有效性分析来确定医疗保险中潜在节省的临床领域;(5)建立研究网络,支持医疗保险相关研究和政策。我们将通过各种活动促进合作和传播,包括全国医疗保险:科学与政策会议,该会议将传播研究成果并促进基于科学的医疗保险改革。 公共卫生相关性:此应用程序侧重于解决方案,以确保医疗保险继续其成功的遗产。我们的多学科团队跨越卫生经济学和政策研究前沿的四个机构,将设计和进行医疗保险相关的研究,政策模拟和福利分析,重点是解决方案,以确保医疗保险继续其成功的遗产。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Careful use of science to advance the debate on the UK Cancer Drugs Fund.
仔细利用科学来推进有关英国癌症药物基金的辩论。
  • DOI:
    10.1001/jama.2013.282839
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lakdawalla,DariusN;Jena,AnupamB;Doctor,JasonN
  • 通讯作者:
    Doctor,JasonN
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets.
知识产权是否限制产出?药品市场分析。
  • DOI:
    10.1086/663345
  • 发表时间:
    2012-02-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lakdawalla D;Philipson T
  • 通讯作者:
    Philipson T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALAN Michael GARBER其他文献

ALAN Michael GARBER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALAN Michael GARBER', 18)}}的其他基金

Estimating the Potential Medicare Savings from Comparative Effectiveness Research
通过比较有效性研究估计潜在的医疗保险节省
  • 批准号:
    8461631
  • 财政年份:
    2011
  • 资助金额:
    $ 550.07万
  • 项目类别:
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
通过比较有效性研究估计潜在的医疗保险节省
  • 批准号:
    8042729
  • 财政年份:
    2011
  • 资助金额:
    $ 550.07万
  • 项目类别:
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
通过比较有效性研究估计潜在的医疗保险节省
  • 批准号:
    8412995
  • 财政年份:
    2011
  • 资助金额:
    $ 550.07万
  • 项目类别:
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
通过比较有效性研究估计潜在的医疗保险节省
  • 批准号:
    8803229
  • 财政年份:
    2011
  • 资助金额:
    $ 550.07万
  • 项目类别:
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
通过比较有效性研究估计潜在的医疗保险节省
  • 批准号:
    8244421
  • 财政年份:
    2011
  • 资助金额:
    $ 550.07万
  • 项目类别:
Center on the Demography and Economics of Health and Aging
人口学和健康与老龄化经济学中心
  • 批准号:
    7931472
  • 财政年份:
    2009
  • 资助金额:
    $ 550.07万
  • 项目类别:
Pilot Core
试点核心
  • 批准号:
    7943334
  • 财政年份:
    2009
  • 资助金额:
    $ 550.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7943333
  • 财政年份:
    2009
  • 资助金额:
    $ 550.07万
  • 项目类别:
Center on the Demography and Economics of Health and Aging
人口学和健康与老龄化经济学中心
  • 批准号:
    7943375
  • 财政年份:
    2009
  • 资助金额:
    $ 550.07万
  • 项目类别:
Center on the Demography and Economics of Health and Aging
人口学和健康与老龄化经济学中心
  • 批准号:
    7943378
  • 财政年份:
    2009
  • 资助金额:
    $ 550.07万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 550.07万
  • 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
  • 批准号:
    400097
  • 财政年份:
    2019
  • 资助金额:
    $ 550.07万
  • 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
  • 批准号:
    19K09017
  • 财政年份:
    2019
  • 资助金额:
    $ 550.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
  • 批准号:
    18K09531
  • 财政年份:
    2018
  • 资助金额:
    $ 550.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
  • 批准号:
    9766994
  • 财政年份:
    2018
  • 资助金额:
    $ 550.07万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 550.07万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 550.07万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 550.07万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9925164
  • 财政年份:
    2016
  • 资助金额:
    $ 550.07万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9345997
  • 财政年份:
    2016
  • 资助金额:
    $ 550.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了